AdamIraSherwatMD
Infectious Disease • Washington, DCAssistant Professor, Medicine, Georgetown University School of Medicine
Are you Dr. Sherwat?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3800 Reservoir Rd Nw
Washington, DC 20007Phone+1 202-687-6845
Summary
- Dr. Adam Sherwat, MD is an infectious disease specialist in Washington, District of Columbia. He is an Assistant Professor at Georgetown University School of Medicine.
Publications & Presentations
PubMed
- 83 citationsTecovirimat and the Treatment of Monkeypox - Past, Present, and Future Considerations.Adam Sherwat, John T Brooks, Debra Birnkrant, Peter Kim
The New England Journal of Medicine. 2022-08-18 - 124 citationsFDA Approval of Remdesivir - A Step in the Right Direction.Daniel B. Rubin, Kirk M Chan-Tack, John Farley, Adam Sherwat
The New England Journal of Medicine. 2020-12-02 - 22 citationsAssessing a drug for an eradicated human disease: US Food and Drug Administration review of tecovirimat for the treatment of smallpox.Kirk M Chan-Tack, Patrick R. Harrington, Su-Young Choi, Laine Myers, Julian J. O'Rear
The Lancet. Infectious Diseases. 2019-06-01
Press Mentions
Sept. 16, 2022: National Advocacy UpdateSeptember 16th, 2022- FDA Warns Monkeypox Could Mutate if Antiviral Drug Is OverusedSeptember 14th, 2022
- What Physicians Need to Know About Tecovirimat (TPOXX) for Treatment of MonkeypoxSeptember 13th, 2022
- Join now to see all
